An innovative initiative by India's leading commodity bourse -- the Multi-Commodity Exchange -- in collaboration with India's Postal Department is making farmers and traders in rural India 'richer.'
Gramin Suvidha Kendra, a joint initiative of MCX and India Post, was launched on April 13 at Dhamangaon sub-post office, 55 km away from Amravati in Maharashtra.
There was a training session at the post office, which was attended by all branch postmasters under Dhamangaon and farmers of these villages.
This is just one of the dozens such similar exercises that MCX has planned to conduct across the rural belt provide market information, warehousing, advisory and agri-input needs of farmers.
MCX officials said the services offered through India Post alliance would make it possible for farmers to avail of, among other things, expert advice on farm-related issues, better market price for their produce, better warehousing facilities, funding against warehouse receipts, quality testing and grading facilities.
For instance, the Dhamangaon subpost office will act as the nodal centre through which villages covered by six branch post offices (Anjansingi, Teora, Kamnapur Ghusli, Wadhona, Juna Dhamangaon and Jalka Patache) linked to it can avail of the GSK service.
MCX provides the infrastructure, such as a computer terminal, the Internet access, a printer, a scanner, a fax machine, a webcam and an electronic MCX commodity price ticker within the premises of the Dhamangaon subpost office.
In order to display market information to farmers and traders, blackboards are being dispatched to the branch post offices. In this way, the computer set up at the sub-post office will address all the requirements of farmers and traders via the concerned branch post offices linked to it.
Farmers and traders would have access to price information and receive responses to queries on support services directly with a central hub for fast and accurate information.
For instance, a farmer could route his query from his village through the postal network to the GSK, where an India PostMCX representative would